Related Experiment Video
Updated: May 7, 2026

07:51
Video Movement Analysis Using Smartphones ViMAS: A Pilot Study
Published on: March 14, 2017
16.7K
Video-based Clinical Gait Analysis in Parkinson's Disease: A Novel Approach Using Frontal Plane Videos and Machine
Summary
This study introduces a cost-effective, machine learning method for analyzing gait using everyday videos. This approach accurately detects Parkinson's disease (PD) gait impairments, improving accessibility for clinical assessment.
Area of Science:
- Neurology
- Biomedical Engineering
- Computer Science
Background:
- Neurological conditions like Parkinson's disease (PD) significantly impair gait.
- Traditional instrumented gait analysis is accurate but costly and inaccessible for widespread clinical use.
- There is a need for accessible, cost-effective gait analysis methods.
Purpose of the Study:
- To develop and validate a machine learning-based method for clinical gait analysis using readily available video devices.
- To assess the feasibility of detecting Parkinson's disease (PD) gait impairments from video recordings.
- To provide a user-friendly and cost-effective solution for remote gait assessment.
Main Methods:
- Utilized open-source body pose (MediaPipe) and metric depth (ZoeDepth) estimators for video analysis.
- Calculated spatiotemporal parameters (STP) of gait from frontal plane videos.
- Validated the method against traditional marker-based motion capture (MoCap) using healthy controls and people with PD (PWP).
Main Results:
- The video-based method demonstrated high agreement and correlation with marker-based motion capture (MoCap).
- Results align with findings from high-end instrumental gait analysis techniques.
- The methodology successfully supported the detection of Parkinson's disease (PD) from gait videos.
Conclusions:
- The proposed method offers an innovative, user-friendly, and cost-effective solution for clinical gait analysis.
- Automated video-based gait analysis can enable telemedicine evaluations for movement decline in individuals with gait impairments.
- This approach has the potential for early PD detection, remote monitoring, and improved management of fall risk.
Related Concept Videos
Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Parkinson Disease l: Introduction
28
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
28
Parkinson Disease ll: Pathophysiology
34
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
34

